Hikal Limited
Equibles does not estimate personal net worth.
Ravi Kharbari has spoken on 1 earnings call across 1 company, most recently for Hikal Limited on November 3, 2026. Hikal Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“For Q2 FY27, the crop protection business reported revenue of 156 crores, EBIT of negative rupees 2 crores, and an EBIT margin of negative 1.5%. In July 527, the crop protection business reported revenue of Rs 326 crores, an EBIT of Rs-8 crores, and an EBIT margin of –2.5%.”
Hikal Limited
Transcript header (unverified)
Hikal Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call for the Quarter Ended September 30, 2026
Hikal Limited
